Since we observed robust inhibition of NFκB in the presence of RIPK2 inhibitor 1 and a > 70 % recovery of animals from DSS - induced inflammation injury (Figs. 4 and 6B), we proceeded to explore the ability to resolve lung inflammation using
the ovalbumin challenge model (Kumar et al., 2008).